Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
132 Leser
Artikel bewerten:
(0)

Actian Corporation: Actian Ushers in New Era of Data Democratization with Federated Data Catalog

Simplifying data discovery and empowering business users with data marketplaces

ROUND ROCK, Texas, Oct. 14, 2024 /PRNewswire/ -- Actian, the data and analytics division of HCLSoftware, today announced the Actian Zeenea Federated Data Catalog, which decentralizes control of data while enabling enterprise-wide visibility and governance. The Actian Zeenea Federated Data Catalog, a feature of the Zeenea Data Discovery Platform, is the first new offering since Actian acquired Zeenea in September 2024 to offer a data intelligence solution enabling customers to discover, govern, and maximize the value of their data assets.

Actian Corporation

Organizations need access to trusted data to gain insight into business conditions, drive better customer experiences, and create new products and solutions. However, traditional centralized data governance models create bottlenecks that slow innovation and decision-making.

"For too long, organizations have been hampered by data silos and rigid governance structures, resulting in the proliferation of unconnected data pools that the rest of the business cannot leverage," said Guillaume Bodet, CPTO at Actian Zeenea. "Our Federated Data Catalog democratizes data by decentralizing governance and giving domains autonomy over their metadata, which results in deeper insights based on a broader set of organizational data."

The Actian Zeenea Federated Data Catalog promotes a decentralized approach to metadata management aligned with domain-oriented ownership, data as a product, self-service access, collaboration for sharing data, and consistent governance. The Federated Data Catalog also enables organizations to establish an Enterprise Data Marketplace, where data can be curated, shared, and consumed as products.

"The ability to find, access, and govern data while adhering to security controls and compliant usage policies has never been more challenging," said Doug Henschen, vice president and principal analyst at Constellation Research. "Data catalogs, like the Actian Zeenea Federated Data Catalog, have become essential to data initiatives to provide awareness of available data within the guardrails of access controls, usage policies, privacy constraints, and regulatory compliance."

A decentralized approach to metadata management

The Actian Zeenea Federated Data Catalog leverages a domain-oriented data management approach where the teams most familiar with the data manage their own data assets, permissions, and governance in a dedicated area of the data catalog. Domains can then publish their curated data in a shared area of the catalog for consumption by all business functions. All users - from technical experts to business users - have self-service access to discover and consume the data via the catalog's intuitive, search engine-like interface. A powerful knowledge graph provides deeper understanding of the concepts and entities, as well as the relationships between them.

Additionally, the Federated Data Catalog establishes the foundation for an Enterprise Data Marketplace where the most valuable assets are shared. The Enterprise Data Marketplace uses an e-commerce-like experience to make data products available to other domains while still maintaining control over who can access or modify them. The common business glossary enables cross-functional teams to collaborate more effectively by aligning on shared terms and definitions.

The Actian Zeenea Federated Data Catalog is available immediately as part of the Zeenea Data Discovery Platform.

About Actian
Actian makes it easy to deliver trusted, high-quality data with a complete set of data management and intelligence portfolio that enables people to discover, manage, and analyze data. With Actian, customers can transform into data-driven organizations that make confident business decisions and accelerate growth. We offer customers choice with a full stack of data solutions delivered via the cloud, hybrid, and on-premises. Actian is a division of HCLSoftware.

Media Contacts
Danielle Lee
Senior Director - Global Analyst Relations & Public Relations
Danielle.Lee@actian.com ?

Ali Wheeler
Public Relations Manager
HKActian@hkstrategies.com

Logo - https://mma.prnewswire.com/media/2429927/Actian_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/actian-ushers-in-new-era-of-data-democratization-with-federated-data-catalog-302274430.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.